Published April 20, 2021
| Version v1
Patent
Open
Method for treating melanoma using lymphangiogenesis inducers and a melanoma-specific antigen
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
The present invention concerns methods and compositions for evoking protective immune responses against pathogen infection or cancer. In certain embodiments, the methods and compositions comprise a lymphangiogenesis inducer and an antigen.
Files
US10980877.pdf
Files
(5.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:0cf4002e639ab4954af6f6a881d968fb
|
5.0 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 10980877 B2
- Patent application number
- US 201716096990 A
- Other
- oai:uchicago.tind.io:7419
Dates
- Patent filed
-
2017-04-28